Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 11 of 11 entries
Sorted by: Best Match Show Resources per page
[In Process Citation].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie

Sabouraud P.
PMID: 10904678
Arch Pediatr. 2000 May;7:119s. doi: 10.1016/s0929-693x(00)80005-6.

No abstract available.

Cite
Sabouraud P. Suivi multidisciplinaire des maladies neuromusculaires. [In Process Citation]. Arch Pediatr. 2000;7:119sdoi: 10.1016/s0929-693x(00)80005-6.
Sabouraud, P. (2000). Suivi multidisciplinaire des maladies neuromusculaires. [In Process Citation]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 7119s. https://doi.org/10.1016/s0929-693x(00)80005-6
Sabouraud. "Suivi multidisciplinaire des maladies neuromusculaires." [In Process Citation]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie vol. 7 (2000): 119s. doi: https://doi.org/10.1016/s0929-693x(00)80005-6
Sabouraud P. Suivi multidisciplinaire des maladies neuromusculaires. [In Process Citation]. Arch Pediatr. 2000 May;7:119s. doi: 10.1016/s0929-693x(00)80005-6. French. PMID: 10904678.
Copy Download .nbib Format: NLM
Real-life experience with hazelnut oral immunotherapy.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology

Sabouraud M, Biermé P, André-Gomez SA, Villard-Truc F, Payot F, Corréard AK, Garnier L, Braun C.
PMID: 35007745
Ann Allergy Asthma Immunol. 2022 Jan 07; doi: 10.1016/j.anai.2022.01.002. Epub 2022 Jan 07.

BACKGROUND: Hazelnut oral immunotherapy (H-OIT), a promising alternative to hazelnut-free diet for patients with hazelnut allergy, has not been extensively studied.OBJECTIVE: The primary objective was to investigate the effectiveness of H-OIT for hazelnut allergic children.METHODS: Retrospective medical record review...

Cite
Sabouraud M, Biermé P, André-Gomez SA, et al. Real-life experience with hazelnut oral immunotherapy. Ann Allergy Asthma Immunol. 2022;doi: 10.1016/j.anai.2022.01.002.
Sabouraud, M., Biermé, P., André-Gomez, S. A., Villard-Truc, F., Payot, F., Corréard, A. K., Garnier, L., & Braun, C. (2022). Real-life experience with hazelnut oral immunotherapy. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, . https://doi.org/10.1016/j.anai.2022.01.002
Sabouraud, Marie, et al. "Real-life experience with hazelnut oral immunotherapy." Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology vol. (2022). doi: https://doi.org/10.1016/j.anai.2022.01.002
Sabouraud M, Biermé P, André-Gomez SA, Villard-Truc F, Payot F, Corréard AK, Garnier L, Braun C. Real-life experience with hazelnut oral immunotherapy. Ann Allergy Asthma Immunol. 2022 Jan 07; doi: 10.1016/j.anai.2022.01.002. Epub 2022 Jan 07. PMID: 35007745.
Copy Download .nbib Format: NLM
Oral immunotherapy in food allergies: A practical update for pediatricians.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie

Sabouraud M, Biermé P, Andre-Gomez SA, Villard-Truc F, Corréard AK, Garnier L, Payot F, Braun C.
PMID: 33858732
Arch Pediatr. 2021 May;28(4):319-324. doi: 10.1016/j.arcped.2021.03.006. Epub 2021 Apr 12.

Food oral immunotherapy (OIT) is a promising treatment for persistent and severe food allergies (FAs) in children, but also for accelerating tolerance to cow's milk and cooked egg in young children. In the near future, pediatricians will increasingly encounter...

Cite
Sabouraud M, Biermé P, Andre-Gomez SA, et al. Oral immunotherapy in food allergies: A practical update for pediatricians. Arch Pediatr. 2021;28(4):319-324doi: 10.1016/j.arcped.2021.03.006.
Sabouraud, M., Biermé, P., Andre-Gomez, S. A., Villard-Truc, F., Corréard, A. K., Garnier, L., Payot, F., & Braun, C. (2021). Oral immunotherapy in food allergies: A practical update for pediatricians. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 28(4), 319-324. https://doi.org/10.1016/j.arcped.2021.03.006
Sabouraud, M, et al. "Oral immunotherapy in food allergies: A practical update for pediatricians." Archives de pediatrie : organe officiel de la Societe francaise de pediatrie vol. 28,4 (2021): 319-324. doi: https://doi.org/10.1016/j.arcped.2021.03.006
Sabouraud M, Biermé P, Andre-Gomez SA, Villard-Truc F, Corréard AK, Garnier L, Payot F, Braun C. Oral immunotherapy in food allergies: A practical update for pediatricians. Arch Pediatr. 2021 May;28(4):319-324. doi: 10.1016/j.arcped.2021.03.006. Epub 2021 Apr 12. PMID: 33858732.
Copy Download .nbib Format: NLM
Non-Ambulant Duchenne Patients Theoretically Treatable by Exon 53 Skipping have Severe Phenotype.

Journal of neuromuscular diseases

Servais L, Montus M, Guiner CL, Ben Yaou R, Annoussamy M, Moraux A, Hogrel JY, Seferian AM, Zehrouni K, Le Moing AG, Gidaro T, Vanhulle C, Laugel V, Butoianu N, Cuisset JM, Sabouraud P, Cances C, Klein A, Leturcq F, Moullier P, Voit T.
PMID: 27858743
J Neuromuscul Dis. 2015 Sep 02;2(3):269-279. doi: 10.3233/JND-150100.

BACKGROUND: Exon skipping therapy is an emerging approach in Duchenne Muscular Dystrophy (DMD). Antisense oligonucleotides that induce skipping of exon 51, 44, 45, or 53 are currently being evaluated in clinical trials. These trials were designed on the basis...

Cite
Servais L, Montus M, Guiner CL, et al. Non-Ambulant Duchenne Patients Theoretically Treatable by Exon 53 Skipping have Severe Phenotype. J Neuromuscul Dis. 2015;2(3):269-279doi: 10.3233/JND-150100.
Servais, L., Montus, M., Guiner, C. L., Ben Yaou, R., Annoussamy, M., Moraux, A., Hogrel, J. Y., Seferian, A. M., Zehrouni, K., Le Moing, A. G., Gidaro, T., Vanhulle, C., Laugel, V., Butoianu, N., Cuisset, J. M., Sabouraud, P., Cances, C., Klein, A., Leturcq, F., Moullier, P., & Voit, T. (2015). Non-Ambulant Duchenne Patients Theoretically Treatable by Exon 53 Skipping have Severe Phenotype. Journal of neuromuscular diseases, 2(3), 269-279. https://doi.org/10.3233/JND-150100
Servais, Laurent, et al. "Non-Ambulant Duchenne Patients Theoretically Treatable by Exon 53 Skipping have Severe Phenotype." Journal of neuromuscular diseases vol. 2,3 (2015): 269-279. doi: https://doi.org/10.3233/JND-150100
Servais L, Montus M, Guiner CL, Ben Yaou R, Annoussamy M, Moraux A, Hogrel JY, Seferian AM, Zehrouni K, Le Moing AG, Gidaro T, Vanhulle C, Laugel V, Butoianu N, Cuisset JM, Sabouraud P, Cances C, Klein A, Leturcq F, Moullier P, Voit T. Non-Ambulant Duchenne Patients Theoretically Treatable by Exon 53 Skipping have Severe Phenotype. J Neuromuscul Dis. 2015 Sep 02;2(3):269-279. doi: 10.3233/JND-150100. PMID: 27858743; PMCID: PMC5240539.
Copy Download .nbib Format: NLM
Palliative Care in SMA Type 1: A Prospective Multicenter French Study Based on Parents' Reports.

Frontiers in pediatrics

Hully M, Barnerias C, Chabalier D, Le Guen S, Germa V, Deladriere E, Vanhulle C, Cuisset JM, Chabrol B, Cances C, Vuillerot C, Espil C, Mayer M, Nougues MC, Sabouraud P, Lefranc J, Laugel V, Rivier F, Louvier UW, Durigneux J, Napuri S, Sarret C, Renouil M, Masurel A, Viallard ML, Desguerre I.
PMID: 32133329
Front Pediatr. 2020 Feb 18;8:4. doi: 10.3389/fped.2020.00004. eCollection 2020.

Spinal muscular atrophy type 1 (SMA-1) is a severe neurodegenerative disorder, which in the absence of curative treatment, leads to death before 1 year of age in most cases. Caring for these short-lived and severely impaired infants requires palliative...

Cite
Hully M, Barnerias C, Chabalier D, et al. Palliative Care in SMA Type 1: A Prospective Multicenter French Study Based on Parents' Reports. Front Pediatr. 2020;8:4doi: 10.3389/fped.2020.00004.
Hully, M., Barnerias, C., Chabalier, D., Le Guen, S., Germa, V., Deladriere, E., Vanhulle, C., Cuisset, J. M., Chabrol, B., Cances, C., Vuillerot, C., Espil, C., Mayer, M., Nougues, M. C., Sabouraud, P., Lefranc, J., Laugel, V., Rivier, F., Louvier, U. W., Durigneux, J., Napuri, S., Sarret, C., Renouil, M., Masurel, A., Viallard, M. L., & Desguerre, I. (2020). Palliative Care in SMA Type 1: A Prospective Multicenter French Study Based on Parents' Reports. Frontiers in pediatrics, 84. https://doi.org/10.3389/fped.2020.00004
Hully, Marie, et al. "Palliative Care in SMA Type 1: A Prospective Multicenter French Study Based on Parents' Reports." Frontiers in pediatrics vol. 8 (2020): 4. doi: https://doi.org/10.3389/fped.2020.00004
Hully M, Barnerias C, Chabalier D, Le Guen S, Germa V, Deladriere E, Vanhulle C, Cuisset JM, Chabrol B, Cances C, Vuillerot C, Espil C, Mayer M, Nougues MC, Sabouraud P, Lefranc J, Laugel V, Rivier F, Louvier UW, Durigneux J, Napuri S, Sarret C, Renouil M, Masurel A, Viallard ML, Desguerre I. Palliative Care in SMA Type 1: A Prospective Multicenter French Study Based on Parents' Reports. Front Pediatr. 2020 Feb 18;8:4. doi: 10.3389/fped.2020.00004. eCollection 2020. PMID: 32133329; PMCID: PMC7039815.
Copy Download .nbib Format: NLM
High-Throughput Digital Image Analysis Reveals Distinct Patterns of Dystrophin Expression in Dystrophinopathy Patients.

Journal of neuropathology and experimental neurology

Torelli S, Scaglioni D, Sardone V, Ellis MJ, Domingos J, Jones A, Feng L, Chambers D, Eastwood DM, Leturcq F, Yaou RB, Urtizberea A, Sabouraud P, Barnerias C, Stojkovic T, Ricci E, Beuvin M, Bonne G, Sewry CA, Willis T, Kulshrestha R, Tasca G, Phadke R, Morgan JE, Muntoni F.
PMID: 34498054
J Neuropathol Exp Neurol. 2021 Oct 26;80(10):955-965. doi: 10.1093/jnen/nlab088.

Duchenne muscular dystrophy (DMD) is an incurable disease caused by out-of-frame DMD gene deletions while in frame deletions lead to the milder Becker muscular dystrophy (BMD). In the last decade several antisense oligonucleotides drugs have been developed to induce...

Cite
Torelli S, Scaglioni D, Sardone V, et al. High-Throughput Digital Image Analysis Reveals Distinct Patterns of Dystrophin Expression in Dystrophinopathy Patients. J Neuropathol Exp Neurol. 2021;80(10):955-965doi: 10.1093/jnen/nlab088.
Torelli, S., Scaglioni, D., Sardone, V., Ellis, M. J., Domingos, J., Jones, A., Feng, L., Chambers, D., Eastwood, D. M., Leturcq, F., Yaou, R. B., Urtizberea, A., Sabouraud, P., Barnerias, C., Stojkovic, T., Ricci, E., Beuvin, M., Bonne, G., Sewry, C. A., Willis, T., Kulshrestha, R., Tasca, G., Phadke, R., Morgan, J. E., & Muntoni, F. (2021). High-Throughput Digital Image Analysis Reveals Distinct Patterns of Dystrophin Expression in Dystrophinopathy Patients. Journal of neuropathology and experimental neurology, 80(10), 955-965. https://doi.org/10.1093/jnen/nlab088
Torelli, Silvia, et al. "High-Throughput Digital Image Analysis Reveals Distinct Patterns of Dystrophin Expression in Dystrophinopathy Patients." Journal of neuropathology and experimental neurology vol. 80,10 (2021): 955-965. doi: https://doi.org/10.1093/jnen/nlab088
Torelli S, Scaglioni D, Sardone V, Ellis MJ, Domingos J, Jones A, Feng L, Chambers D, Eastwood DM, Leturcq F, Yaou RB, Urtizberea A, Sabouraud P, Barnerias C, Stojkovic T, Ricci E, Beuvin M, Bonne G, Sewry CA, Willis T, Kulshrestha R, Tasca G, Phadke R, Morgan JE, Muntoni F. High-Throughput Digital Image Analysis Reveals Distinct Patterns of Dystrophin Expression in Dystrophinopathy Patients. J Neuropathol Exp Neurol. 2021 Oct 26;80(10):955-965. doi: 10.1093/jnen/nlab088. PMID: 34498054; PMCID: PMC8557329.
Copy Download .nbib Format: NLM
International retrospective natural history study of .

Brain communications

Ben Yaou R, Yun P, Dabaj I, Norato G, Donkervoort S, Xiong H, Nascimento A, Maggi L, Sarkozy A, Monges S, Bertoli M, Komaki H, Mayer M, Mercuri E, Zanoteli E, Castiglioni C, Marini-Bettolo C, D'Amico A, Deconinck N, Desguerre I, Erazo-Torricelli R, Gurgel-Giannetti J, Ishiyama A, Kleinsteuber KS, Lagrue E, Laugel V, Mercier S, Messina S, Politano L, Ryan MM, Sabouraud P, Schara U, Siciliano G, Vercelli L, Voit T, Yoon G, Alvarez R, Muntoni F, Pierson TM, Gómez-Andrés D, Reghan Foley A, Quijano-Roy S, Bönnemann CG, Bonne G.
PMID: 34240052
Brain Commun. 2021 Apr 11;3(3):fcab075. doi: 10.1093/braincomms/fcab075. eCollection 2021 Jul.

Muscular dystrophies due to heterozygous pathogenic variants in

Cite
Ben Yaou R, Yun P, Dabaj I, et al. International retrospective natural history study of . Brain Commun. 2021;3(3):fcab075doi: 10.1093/braincomms/fcab075.
Ben Yaou, R., Yun, P., Dabaj, I., Norato, G., Donkervoort, S., Xiong, H., Nascimento, A., Maggi, L., Sarkozy, A., Monges, S., Bertoli, M., Komaki, H., Mayer, M., Mercuri, E., Zanoteli, E., Castiglioni, C., Marini-Bettolo, C., D'Amico, A., Deconinck, N., Desguerre, I., Erazo-Torricelli, R., Gurgel-Giannetti, J., Ishiyama, A., Kleinsteuber, K. S., Lagrue, E., Laugel, V., Mercier, S., Messina, S., Politano, L., Ryan, M. M., Sabouraud, P., Schara, U., Siciliano, G., Vercelli, L., Voit, T., Yoon, G., Alvarez, R., Muntoni, F., Pierson, T. M., Gómez-Andrés, D., Reghan Foley, A., Quijano-Roy, S., Bönnemann, C. G., & Bonne, G. (2021). International retrospective natural history study of . Brain communications, 3(3), fcab075. https://doi.org/10.1093/braincomms/fcab075
Ben Yaou, Rabah, et al. "International retrospective natural history study of ." Brain communications vol. 3,3 (2021): fcab075. doi: https://doi.org/10.1093/braincomms/fcab075
Ben Yaou R, Yun P, Dabaj I, Norato G, Donkervoort S, Xiong H, Nascimento A, Maggi L, Sarkozy A, Monges S, Bertoli M, Komaki H, Mayer M, Mercuri E, Zanoteli E, Castiglioni C, Marini-Bettolo C, D'Amico A, Deconinck N, Desguerre I, Erazo-Torricelli R, Gurgel-Giannetti J, Ishiyama A, Kleinsteuber KS, Lagrue E, Laugel V, Mercier S, Messina S, Politano L, Ryan MM, Sabouraud P, Schara U, Siciliano G, Vercelli L, Voit T, Yoon G, Alvarez R, Muntoni F, Pierson TM, Gómez-Andrés D, Reghan Foley A, Quijano-Roy S, Bönnemann CG, Bonne G. International retrospective natural history study of . Brain Commun. 2021 Apr 11;3(3):fcab075. doi: 10.1093/braincomms/fcab075. eCollection 2021 Jul. PMID: 34240052; PMCID: PMC8260964.
Copy Download .nbib Format: NLM
Skeletal Ryanodine Receptors Are Involved in Impaired Myogenic Differentiation in Duchenne Muscular Dystrophy Patients.

International journal of molecular sciences

Meyer P, Notarnicola C, Meli AC, Matecki S, Hugon G, Salvador J, Khalil M, Féasson L, Cances C, Cottalorda J, Desguerre I, Cuisset JM, Sabouraud P, Lacampagne A, Chevassus H, Rivier F, Carnac G.
PMID: 34884796
Int J Mol Sci. 2021 Nov 30;22(23). doi: 10.3390/ijms222312985.

Duchenne muscular dystrophy (DMD) is characterized by progressive muscle wasting following repeated muscle damage and inadequate regeneration. Impaired myogenesis and differentiation play a major role in DMD as well as intracellular calcium (Ca

Cite
Meyer P, Notarnicola C, Meli AC, et al. Skeletal Ryanodine Receptors Are Involved in Impaired Myogenic Differentiation in Duchenne Muscular Dystrophy Patients. Int J Mol Sci. 2021;22(23)doi: 10.3390/ijms222312985.
Meyer, P., Notarnicola, C., Meli, A. C., Matecki, S., Hugon, G., Salvador, J., Khalil, M., Féasson, L., Cances, C., Cottalorda, J., Desguerre, I., Cuisset, J. M., Sabouraud, P., Lacampagne, A., Chevassus, H., Rivier, F., & Carnac, G. (2021). Skeletal Ryanodine Receptors Are Involved in Impaired Myogenic Differentiation in Duchenne Muscular Dystrophy Patients. International journal of molecular sciences, 22(23), . https://doi.org/10.3390/ijms222312985
Meyer, Pierre, et al. "Skeletal Ryanodine Receptors Are Involved in Impaired Myogenic Differentiation in Duchenne Muscular Dystrophy Patients." International journal of molecular sciences vol. 22,23 (2021). doi: https://doi.org/10.3390/ijms222312985
Meyer P, Notarnicola C, Meli AC, Matecki S, Hugon G, Salvador J, Khalil M, Féasson L, Cances C, Cottalorda J, Desguerre I, Cuisset JM, Sabouraud P, Lacampagne A, Chevassus H, Rivier F, Carnac G. Skeletal Ryanodine Receptors Are Involved in Impaired Myogenic Differentiation in Duchenne Muscular Dystrophy Patients. Int J Mol Sci. 2021 Nov 30;22(23). doi: 10.3390/ijms222312985. PMID: 34884796.
Copy Download .nbib Format: NLM
Skeletal Ryanodine Receptors Are Involved in Impaired Myogenic Differentiation in Duchenne Muscular Dystrophy Patients.

International journal of molecular sciences

Meyer P, Notarnicola C, Meli AC, Matecki S, Hugon G, Salvador J, Khalil M, Féasson L, Cances C, Cottalorda J, Desguerre I, Cuisset JM, Sabouraud P, Lacampagne A, Chevassus H, Rivier F, Carnac G.
PMID: 34884796
Int J Mol Sci. 2021 Nov 30;22(23). doi: 10.3390/ijms222312985.

Duchenne muscular dystrophy (DMD) is characterized by progressive muscle wasting following repeated muscle damage and inadequate regeneration. Impaired myogenesis and differentiation play a major role in DMD as well as intracellular calcium (Ca

Cite
Meyer P, Notarnicola C, Meli AC, et al. Skeletal Ryanodine Receptors Are Involved in Impaired Myogenic Differentiation in Duchenne Muscular Dystrophy Patients. Int J Mol Sci. 2021;22(23)doi: 10.3390/ijms222312985.
Meyer, P., Notarnicola, C., Meli, A. C., Matecki, S., Hugon, G., Salvador, J., Khalil, M., Féasson, L., Cances, C., Cottalorda, J., Desguerre, I., Cuisset, J. M., Sabouraud, P., Lacampagne, A., Chevassus, H., Rivier, F., & Carnac, G. (2021). Skeletal Ryanodine Receptors Are Involved in Impaired Myogenic Differentiation in Duchenne Muscular Dystrophy Patients. International journal of molecular sciences, 22(23), . https://doi.org/10.3390/ijms222312985
Meyer, Pierre, et al. "Skeletal Ryanodine Receptors Are Involved in Impaired Myogenic Differentiation in Duchenne Muscular Dystrophy Patients." International journal of molecular sciences vol. 22,23 (2021). doi: https://doi.org/10.3390/ijms222312985
Meyer P, Notarnicola C, Meli AC, Matecki S, Hugon G, Salvador J, Khalil M, Féasson L, Cances C, Cottalorda J, Desguerre I, Cuisset JM, Sabouraud P, Lacampagne A, Chevassus H, Rivier F, Carnac G. Skeletal Ryanodine Receptors Are Involved in Impaired Myogenic Differentiation in Duchenne Muscular Dystrophy Patients. Int J Mol Sci. 2021 Nov 30;22(23). doi: 10.3390/ijms222312985. PMID: 34884796; PMCID: PMC8657486.
Copy Download .nbib Format: NLM
Walter John Nickerson, Professor of Microbiology at the Waksman Institute of Microbiology.

Sabouraudia

[No authors listed]
PMID: 394370
Sabouraudia. 1979 Sep;17(3):341.

No abstract available.

Cite
Walter John Nickerson, Professor of Microbiology at the Waksman Institute of Microbiology. Sabouraudia. 1979;17(3):341
(1979). Walter John Nickerson, Professor of Microbiology at the Waksman Institute of Microbiology. Sabouraudia, 17(3), 341.
"Walter John Nickerson, Professor of Microbiology at the Waksman Institute of Microbiology." Sabouraudia vol. 17,3 (1979): 341.
Walter John Nickerson, Professor of Microbiology at the Waksman Institute of Microbiology. Sabouraudia. 1979 Sep;17(3):341. PMID: 394370.
Copy Download .nbib Format: NLM
High-Throughput Digital Image Analysis Reveals Distinct Patterns of Dystrophin Expression in Dystrophinopathy Patients.

Journal of neuropathology and experimental neurology

Torelli S, Scaglioni D, Sardone V, Ellis MJ, Domingos J, Jones A, Feng L, Chambers D, Eastwood DM, Leturcq F, Yaou RB, Urtizberea A, Sabouraud P, Barnerias C, Stojkovic T, Ricci E, Beuvin M, Bonne G, Sewry CA, Willis T, Kulshrestha R, Tasca G, Phadke R, Morgan JE, Muntoni F.
PMID: 34498054
J Neuropathol Exp Neurol. 2021 Oct 26;80(10):955-965. doi: 10.1093/jnen/nlab088.

Duchenne muscular dystrophy (DMD) is an incurable disease caused by out-of-frame DMD gene deletions while in frame deletions lead to the milder Becker muscular dystrophy (BMD). In the last decade several antisense oligonucleotides drugs have been developed to induce...

Cite
Torelli S, Scaglioni D, Sardone V, et al. High-Throughput Digital Image Analysis Reveals Distinct Patterns of Dystrophin Expression in Dystrophinopathy Patients. J Neuropathol Exp Neurol. 2021;80(10):955-965doi: 10.1093/jnen/nlab088.
Torelli, S., Scaglioni, D., Sardone, V., Ellis, M. J., Domingos, J., Jones, A., Feng, L., Chambers, D., Eastwood, D. M., Leturcq, F., Yaou, R. B., Urtizberea, A., Sabouraud, P., Barnerias, C., Stojkovic, T., Ricci, E., Beuvin, M., Bonne, G., Sewry, C. A., Willis, T., Kulshrestha, R., Tasca, G., Phadke, R., Morgan, J. E., & Muntoni, F. (2021). High-Throughput Digital Image Analysis Reveals Distinct Patterns of Dystrophin Expression in Dystrophinopathy Patients. Journal of neuropathology and experimental neurology, 80(10), 955-965. https://doi.org/10.1093/jnen/nlab088
Torelli, Silvia, et al. "High-Throughput Digital Image Analysis Reveals Distinct Patterns of Dystrophin Expression in Dystrophinopathy Patients." Journal of neuropathology and experimental neurology vol. 80,10 (2021): 955-965. doi: https://doi.org/10.1093/jnen/nlab088
Torelli S, Scaglioni D, Sardone V, Ellis MJ, Domingos J, Jones A, Feng L, Chambers D, Eastwood DM, Leturcq F, Yaou RB, Urtizberea A, Sabouraud P, Barnerias C, Stojkovic T, Ricci E, Beuvin M, Bonne G, Sewry CA, Willis T, Kulshrestha R, Tasca G, Phadke R, Morgan JE, Muntoni F. High-Throughput Digital Image Analysis Reveals Distinct Patterns of Dystrophin Expression in Dystrophinopathy Patients. J Neuropathol Exp Neurol. 2021 Oct 26;80(10):955-965. doi: 10.1093/jnen/nlab088. PMID: 34498054; PMCID: PMC8557329.
Copy Download .nbib Format: NLM
Showing 1 to 11 of 11 entries